<DOC>
	<DOCNO>NCT02584582</DOCNO>
	<brief_summary>Aim : To investigate glucagonostatic effect glucagon-like peptide-1 ( GLP-1 ) independent gastric empty rate .</brief_summary>
	<brief_title>The Effect GLP-1 Postprandial Glucagon Secretion Independent The Gastric Emptying Rate</brief_title>
	<detailed_description>Aim : To investigate glucagonostatic effect glucagon-like peptide-1 ( GLP-1 ) prolong intermittent stimulation GLP-1 receptor independent gastric empty rate . Glucagon concentration measure follow liquid meal administer duodenum baseline exenatide , liraglutide treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Type 1 Diabetes &gt; 18 year No residual betacell function ( stimulate Cpeptide &lt; 60 pmol ) Pancreatitis gastroparesis history alcohol and/or drug abuse pregnancy lactation medical psychological condition make patient unsuitable study participation accord investigatorsÂ´ assessment contraindication gastroscopy cancer ( unless complete remission &gt; five year )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Glucagon</keyword>
	<keyword>Glukagon-like peptide-1 ( GLP-1 )</keyword>
	<keyword>GLP-1 receptor agonist ( GLP-1RA )</keyword>
	<keyword>Incretins</keyword>
</DOC>